Literature DB >> 10023370

Syndromic approach to STD case management: where do we go from here?

C J van Dam1, K M Becker, F Ndowa, M Q Islam.   

Abstract

In the absence of aetiological tests for the diagnosis of individual sexually transmitted diseases (STD), the syndromic approach has been developed as an effective and appropriate case management strategy. Algorithms provide guidance to healthcare workers and ensure standardised approaches to case management. The syndromic approach, utilising currently available algorithms, works well in the management of people with symptomatic urethritis, genital ulcer disease, and vaginitis. Owing to the frequently asymptomatic nature of gonococcal and/or chlamydial cervicitis, and the lack of specific defining risk factors and/or signs and symptoms, the syndromic approach performs less well in the identification and management of women with cervicitis. The syndromic approach can and should be adopted for the management of patients with urethral discharge, genital ulceration, vaginal discharge, and cervical signs. Further research is needed to improve the identification and management of cervical infections; to guide policy makers in selecting the most appropriate disease control strategy; to improve utilisation of available and future tests; to develop affordable, rapid, and simple diagnostic tests; and to develop STD vaccines.

Entities:  

Mesh:

Year:  1998        PMID: 10023370

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  7 in total

1.  Prevalence and risk assessment for sexually transmitted infections in pregnant women and female sex workers in Mali: is syndromic approach suitable for screening?

Authors:  C Mulanga-Kabeya; E Morel; D Patrel; E Delaporte; F Bougoudogo; Y I Maiga; Z Diawara; I Ndoye; S Garangué; D Henzel
Journal:  Sex Transm Infect       Date:  1999-10       Impact factor: 3.519

2.  Chlamydia and gonorrhoea in pregnancy: effectiveness of diagnosis and treatment in Botswana.

Authors:  M Romoren; M Rahman; J Sundby; P Hjortdahl
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

3.  Sexually transmitted infections in male clients of female sex workers in Benin: risk factors and reassessment of the leucocyte esterase dipstick for screening of urethral infections.

Authors:  M Alary; C M Lowndes; L Mukenge-Tshibaka; C A B Gnintoungbé; E Bédard; N Geraldo; P Jossou; E Lafia; F Bernier; E Baganizi; J R Joly; E Frost; S Anagonou
Journal:  Sex Transm Infect       Date:  2003-10       Impact factor: 3.519

4.  Syndromic and laboratory diagnosis of sexually transmitted infection: a comparative study in China.

Authors:  Yue-ping Yin; Zunyou Wu; Chunqing Lin; Jihui Guan; Yi Wen; Li Li; Roger Detels; Mary Jane Rotheram-Borus
Journal:  Int J STD AIDS       Date:  2008-06       Impact factor: 1.359

5.  Prevalence of sexually transmitted infections and performance of STI syndromes against aetiological diagnosis, in female sex workers of red light area in Surat, India.

Authors:  V K Desai; J K Kosambiya; H G Thakor; D D Umrigar; B R Khandwala; K K Bhuyan
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

6.  Effectiveness of syndromic management for male patients with urethral discharge symptoms in Amazonas, Brazil.

Authors:  Jonas Rodrigues de Menezes Filho; José Carlos Gomes Sardinha; Enrique Galbán; Valéria Saraceni; Carolina Talhari
Journal:  An Bras Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.896

7.  Performance of syndromic management for the detection and treatment of genital Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis among women attending antenatal, well woman and sexual health clinics in Papua New Guinea: a cross-sectional study.

Authors:  Lisa M Vallely; Pamela Toliman; Claire Ryan; Glennis Rai; Johanna Wapling; Josephine Gabuzzi; Joyce Allen; Christine Opa; Gloria Munnull; Petronia Kaima; Benny Kombuk; Antonia Kumbia; Zure Kombati; Greg Law; Angela Kelly-Hanku; Handan Wand; Peter M Siba; Glen D L Mola; John M Kaldor; Andrew J Vallely
Journal:  BMJ Open       Date:  2017-12-29       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.